» Articles » PMID: 37291333

Carnitine Palmitoyltransferase 1A Promotes Mitochondrial Fission by Enhancing MFF Succinylation in Ovarian Cancer

Overview
Journal Commun Biol
Specialty Biology
Date 2023 Jun 8
PMID 37291333
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are dynamic organelles that are important for cell growth and proliferation. Dysregulated mitochondrial dynamics are highly associated with the initiation and progression of various cancers, including ovarian cancer. However, the regulatory mechanism underlying mitochondrial dynamics is still not fully understood. Previously, our study showed that carnitine palmitoyltransferase 1A (CPT1A) is highly expressed in ovarian cancer cells and promotes the development of ovarian cancer. Here, we find that CPT1A regulates mitochondrial dynamics and promotes mitochondrial fission in ovarian cancer cells. Our study futher shows that CPT1A regulates mitochondrial fission and function through mitochondrial fission factor (MFF) to promote the growth and proliferation of ovarian cancer cells. Mechanistically, we show that CPT1A promotes succinylation of MFF at lysine 302 (K302), which protects against Parkin-mediated ubiquitin-proteasomal degradation of MFF. Finally, the study shows that MFF is highly expressed in ovarian cancer cells and that high MFF expression is associated with poor prognosis in patients with ovarian cancer. MFF inhibition significantly inhibits the progression of ovarian cancer in vivo. Overall, CPT1A regulates mitochondrial dynamics through MFF succinylation to promote the development of ovarian cancer. Moreover, our findings suggest that MFF is a potential therapeutic target for ovarian cancer.

Citing Articles

CPT1A Alleviates Senescence and Restores Osteogenic Differentiation of BM-MSC Through SOD2 Succinylation.

Wang X, Liu S, Chen X, Yan L, Li L, Le He G J Cell Mol Med. 2025; 29(5):e70473.

PMID: 40070041 PMC: 11897055. DOI: 10.1111/jcmm.70473.


CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells.

Zhu Y, Chen S, Su H, Meng Y, Zang C, Ning P Commun Biol. 2025; 8(1):250.

PMID: 39956875 PMC: 11830779. DOI: 10.1038/s42003-025-07720-w.


CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK/T-cell lymphoma nasal type.

Tian H, Ge Y, Yu J, Chen X, Wang H, Cai X Cell Biol Toxicol. 2025; 41(1):42.

PMID: 39934546 PMC: 11814014. DOI: 10.1007/s10565-025-09994-6.


Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation.

Zheng Z, Xiao P, Kuang J, Wang Z, Wang X, Huang D J Cancer. 2025; 16(3):821-834.

PMID: 39781339 PMC: 11705062. DOI: 10.7150/jca.105849.


The Role of the CPT Family in Cancer: Searching for New Therapeutic Strategies.

Duan Y, Liu J, Li A, Liu C, Shu G, Yin G Biology (Basel). 2024; 13(11).

PMID: 39596847 PMC: 11592116. DOI: 10.3390/biology13110892.


References
1.
Sheng J, Li H, Dai Q, Lu C, Xu M, Zhang J . NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy. Cell Physiol Biochem. 2018; 48(4):1675-1693. DOI: 10.1159/000492292. View

2.
Prip-Buus C, Thuillier L, Abadi N, Prasad C, Dilling L, Klasing J . Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community. Mol Genet Metab. 2001; 73(1):46-54. DOI: 10.1006/mgme.2001.3176. View

3.
Li X, Wu Q, Ma F, Zhang X, Cai L, Yang X . Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai). 2022; 54(3):301-310. PMC: 9828151. DOI: 10.3724/abbs.2022007. View

4.
Yan X, Li P, Zhan Y, Qi M, Liu J, An Z . Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation. Biochem Pharmacol. 2018; 150:72-85. DOI: 10.1016/j.bcp.2018.01.031. View

5.
Liu G, Luo Q, Li H, Liu Q, Ju Y, Song G . Increased Oxidative Phosphorylation Is Required for Stemness Maintenance in Liver Cancer Stem Cells from Hepatocellular Carcinoma Cell Line HCCLM3 Cells. Int J Mol Sci. 2020; 21(15). PMC: 7432880. DOI: 10.3390/ijms21155276. View